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Background:  Data on the exact incidence and predictors of left ventricular (LV) thrombus formation after primary percutaneous coronary 
intervention (PCI) for ST-elevation myocardial infarction (STEMI) are scarce. Moreover, data on the prognostic significance of LV thrombi 
on hard clinical outcome measures are completely lacking. Non-invasive investigation by gadolinium-enhanced cardiac magnetic 
resonance imaging (CMR) enables the detection of LV thrombi with high spatial resolution and superior diagnostic accuracy as compared 
to echocardiography. Aim of our study was 1) to assess the incidence, determinants and clinical characteristics of LV thrombi in a large 
multicenter cohort of high-risk STEMI patients, 2) to assess the prognostic significance of LV thrombi at one-year follow-up.
methods:  We enrolled 780 STEMI patients reperfused by primary angioplasty (<12 h after symptom onset) in this CMR study at 8 centers. 
CMR was completed within one week after infarction using a standardized protocol. Central core lab-masked analyses for the presence of 
LV thrombi were performed. The primary clinical endpoint of the study was the occurrence of major adverse cardiac events (MACE) at one 
year follow-up.
results:  LV thrombi were detected in 32 patients (4.1%). The presence of LV thrombi was associated with larger infarcts (p<0.001), 
less myocardial salvage (p<0.001), impaired LV ejection fraction (p=0.02) and more pronounced reperfusion injury (late microvascular 
obstruction p=0.004, intramyocardial hemorrhage p=0.02). In multivariable regression analysis infarct size, anterior infarction, age and 
pain-to-balloon time emerged as significant predictors of LV thrombi. Patients with LV thrombi had a significantly higher MACE rate at 
12-month follow-up (p<0.001).
conclusion:  In this large multicenter cohort of patients with STEMI, thrombus prevalence was 4.1% by CMR. The presence of LV thrombi 
is associated with decreased myocardial salvage, larger infarcts, and more pronounced reperfusion injury with subsequent significantly 
increased MACE rates. Consequently, our data underscore the importance of LV thrombi as a marker of poor outcome in STEMI patients.
